X4 Pharmaceuticals Inc (XFOR)
0.3679
+0.09
(+34.12%)
USD |
NASDAQ |
Nov 14, 12:31
X4 Pharmaceuticals Shareholders Equity (Quarterly): 94.45M for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 94.45M |
| March 31, 2024 | 1.036M |
| December 31, 2023 | 51.10M |
| September 30, 2023 | 67.59M |
| June 30, 2023 | 67.54M |
| March 31, 2023 | 51.68M |
| December 31, 2022 | 74.05M |
| September 30, 2022 | 61.85M |
| June 30, 2022 | 30.07M |
| March 31, 2022 | 49.71M |
| December 31, 2021 | 64.41M |
| September 30, 2021 | 68.68M |
| June 30, 2021 | 89.21M |
| March 31, 2021 | 106.94M |
| December 31, 2020 | 72.80M |
| Date | Value |
|---|---|
| September 30, 2020 | 89.71M |
| June 30, 2020 | 104.88M |
| March 31, 2020 | 118.79M |
| December 31, 2019 | 129.22M |
| September 30, 2019 | 79.11M |
| June 30, 2019 | 96.17M |
| March 31, 2019 | 29.44M |
| December 31, 2018 | 21.60M |
| September 30, 2018 | 27.90M |
| June 30, 2018 | 37.76M |
| March 31, 2018 | 48.42M |
| December 31, 2017 | 58.71M |
| September 30, 2017 | 11.60M |
| December 31, 2016 | -56.56M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
1.036M
Minimum
Mar 2024
129.22M
Maximum
Dec 2019
73.35M
Average
68.68M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -0.617M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 27.65M |
| Oragenics Inc | 1.326M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 210.61M |
| Total Liabilities (Quarterly) | 116.16M |
| Debt to Equity Ratio | 0.7944 |
| Current Ratio | 6.069 |
| Net Debt Paydown Yield | -8.74% |